tiprankstipranks
Eisai Co Ltd (ESALF)
OTHER OTC:ESALF
US Market
Want to see ESALF full AI Analyst Report?

Eisai Co (ESALF) Stock Forecast & Price Target

36 Followers
See the Price Targets and Ratings of:

ESALF Analyst Ratings

Hold
1Ratings
Hold
0 Buy
1 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Eisai
Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ESALF Stock 12 Month Forecast

Average Price Target

$31.41
▲(3.17% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Eisai Co in the last 3 months. The average price target is $31.41 with a high forecast of $31.41 and a low forecast of $31.41. The average price target represents a 3.17% change from the last price of $30.44.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"25":"$25","36":"$36","27.75":"$27.8","30.5":"$30.5","33.25":"$33.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":31.405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$31.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$31.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.405,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$31.41</span>\n  </div></div>","useHTML":true}}],"tickPositions":[25,27.75,30.5,33.25,36],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.705,29.83576923076923,29.96653846153846,30.09730769230769,30.228076923076923,30.35884615384615,30.489615384615384,30.620384615384616,30.751153846153848,30.881923076923076,31.01269230769231,31.14346153846154,31.27423076923077,{"y":31.405,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.705,29.83576923076923,29.96653846153846,30.09730769230769,30.228076923076923,30.35884615384615,30.489615384615384,30.620384615384616,30.751153846153848,30.881923076923076,31.01269230769231,31.14346153846154,31.27423076923077,{"y":31.405,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,29.705,29.83576923076923,29.96653846153846,30.09730769230769,30.228076923076923,30.35884615384615,30.489615384615384,30.620384615384616,30.751153846153848,30.881923076923076,31.01269230769231,31.14346153846154,31.27423076923077,{"y":31.405,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":27.78,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.175,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.059,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.065,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27.581,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.233,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.171,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.943,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.286,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":34.417,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.275,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":29.705,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$31.41Average Price Target$31.41Lowest Price Target$31.41
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$31.41
Hold
3.17%
Upside
Reiterated
04/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alfresa Holdings (Other OTC: ARHCF), Spyre Therapeutics (NASDAQ: SYRE) and Eisai Co (Other OTC: ESALF)
Bernstein Analyst forecast on ESALF
Bernstein
Bernstein
$38.31
Buy
25.87%
Upside
Reiterated
01/16/26
Bernstein Sticks to Their Buy Rating for Eisai Co (ESALF)
Goldman Sachs Analyst forecast on ESALF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$34.55$29.83
Hold
-1.99%
Downside
Reiterated
12/17/25
Eisai Co (ESALF) Gets a Hold from Goldman Sachs
Macquarie Analyst forecast on ESALF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$31.41$34.55
Buy
13.49%
Upside
Reiterated
10/14/25
Macquarie Sticks to Its Buy Rating for Eisai Co (ESALF)
Citi
$37.06$38.94
Buy
27.93%
Upside
Reiterated
09/12/25
Citi Sticks to Its Buy Rating for Eisai Co (ESALF)
J.P. Morgan Analyst forecast on ESALF
J.P. Morgan
J.P. Morgan
$25.12$30.78
Hold
1.11%
Upside
Reiterated
09/04/25
J.P. Morgan Sticks to Their Hold Rating for Eisai Co (ESALF)
UBS
$47.11$31.41
Buy
3.17%
Upside
Reiterated
06/05/25
UBS Remains a Buy on Eisai Co (ESALF)
Morgan Stanley Analyst forecast on ESALF
Morgan Stanley
Morgan Stanley
$25.75
Hold
-15.40%
Downside
Reiterated
05/29/25
Morgan Stanley Sticks to Their Hold Rating for Eisai Co (ESALF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
$31.41
Hold
3.17%
Upside
Reiterated
04/14/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Alfresa Holdings (Other OTC: ARHCF), Spyre Therapeutics (NASDAQ: SYRE) and Eisai Co (Other OTC: ESALF)
Bernstein Analyst forecast on ESALF
Bernstein
Bernstein
$38.31
Buy
25.87%
Upside
Reiterated
01/16/26
Bernstein Sticks to Their Buy Rating for Eisai Co (ESALF)
Goldman Sachs Analyst forecast on ESALF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$34.55$29.83
Hold
-1.99%
Downside
Reiterated
12/17/25
Eisai Co (ESALF) Gets a Hold from Goldman Sachs
Macquarie Analyst forecast on ESALF
Unknown Analyst
Macquarie
Not Ranked
Macquarie
$31.41$34.55
Buy
13.49%
Upside
Reiterated
10/14/25
Macquarie Sticks to Its Buy Rating for Eisai Co (ESALF)
Citi
$37.06$38.94
Buy
27.93%
Upside
Reiterated
09/12/25
Citi Sticks to Its Buy Rating for Eisai Co (ESALF)
J.P. Morgan Analyst forecast on ESALF
J.P. Morgan
J.P. Morgan
$25.12$30.78
Hold
1.11%
Upside
Reiterated
09/04/25
J.P. Morgan Sticks to Their Hold Rating for Eisai Co (ESALF)
UBS
$47.11$31.41
Buy
3.17%
Upside
Reiterated
06/05/25
UBS Remains a Buy on Eisai Co (ESALF)
Morgan Stanley Analyst forecast on ESALF
Morgan Stanley
Morgan Stanley
$25.75
Hold
-15.40%
Downside
Reiterated
05/29/25
Morgan Stanley Sticks to Their Hold Rating for Eisai Co (ESALF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Eisai Co

3 Months
Miki SogiBernstein
Success Rate
4/7 ratings generated profit
57%
Average Return
+0.87%
Copying Miki Sogi's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +0.87% per trade.
1 Year
Miki SogiBernstein
Success Rate
3/7 ratings generated profit
43%
Average Return
+4.20%
Copying Miki Sogi's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +4.20% per trade.
2 Years
Miki SogiBernstein
Success Rate
3/7 ratings generated profit
43%
Average Return
-0.50%
Copying Miki Sogi's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -0.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ESALF Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
2
2
2
0
0
Hold
1
1
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
2
1
1
In the current month, ESALF has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ESALF average Analyst price target in the past 3 months is 31.41.
Each month's total comprises the sum of three months' worth of ratings.

ESALF Financial Forecast

ESALF Earnings Forecast

Next quarter’s earnings estimate for ESALF is $0.40 with a range of $0.23 to $0.50. The previous quarter’s EPS was -$0.07. ESALF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ESALF has Performed in-line its overall industry.
Next quarter’s earnings estimate for ESALF is $0.40 with a range of $0.23 to $0.50. The previous quarter’s EPS was -$0.07. ESALF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year ESALF has Performed in-line its overall industry.

ESALF Sales Forecast

Next quarter’s sales forecast for ESALF is $1.37B with a range of $1.28B to $1.45B. The previous quarter’s sales results were $1.29B. ESALF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ESALF has Performed in-line its overall industry.
Next quarter’s sales forecast for ESALF is $1.37B with a range of $1.28B to $1.45B. The previous quarter’s sales results were $1.29B. ESALF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year ESALF has Performed in-line its overall industry.

ESALF Stock Forecast FAQ

What is ESALF’s average 12-month price target, according to analysts?
Based on analyst ratings, Eisai Co Ltd’s 12-month average price target is 31.41.
    What is ESALF’s upside potential, based on the analysts’ average price target?
    Eisai Co Ltd has 3.17% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ESALF a Buy, Sell or Hold?
          Eisai Co Ltd has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Eisai Co Ltd’s price target?
            The average price target for Eisai Co Ltd is 31.41. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $31.41 ,the lowest forecast is $31.41. The average price target represents 3.17% Increase from the current price of $30.44.
              What do analysts say about Eisai Co Ltd?
              Eisai Co Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of ESALF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.